Axa’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-238,989
| Closed | -$7.94M | – | 1362 |
|
|
2017
Q2 | $7.94M | Buy |
238,989
+1,476
| +0.6% | +$49K | 0.04% | 486 |
|
|
2017
Q1 | $7.62M | Sell |
237,513
-3,499
| -1% | -$112K | 0.03% | 495 |
|
|
2016
Q4 | $8.74M | Sell |
241,012
-377
| -0.2% | -$13.7K | 0.04% | 439 |
|
|
2016
Q3 | $11.1M | Buy |
241,389
+3,679
| +2% | +$169K | 0.05% | 368 |
|
|
2016
Q2 | $11.9M | Buy |
237,710
+36,088
| +18% | +$1.81M | 0.05% | 343 |
|
|
2016
Q1 | $10.8M | Sell |
201,622
-202
| -0.1% | -$10.8K | 0.05% | 377 |
|
|
2015
Q4 | $13.2M | Buy |
201,824
+2,674
| +1% | +$176K | 0.06% | 318 |
|
|
2015
Q3 | $11.2M | Buy |
199,150
+3,652
| +2% | +$206K | 0.05% | 355 |
|
|
2015
Q2 | $11.6M | Buy |
195,498
+2,233
| +1% | +$132K | 0.05% | 390 |
|
|
2015
Q1 | $12M | Sell |
193,265
-95,805
| -33% | -$5.97M | 0.05% | 363 |
|
|
2014
Q4 | $16.6M | Buy |
289,070
+4,002
| +1% | +$230K | 0.07% | 293 |
|
|
2014
Q3 | $15.3M | Buy |
285,068
+5,329
| +2% | +$286K | 0.07% | 294 |
|
|
2014
Q2 | $14.7M | Buy |
+279,739
| New | +$14.7M | 0.06% | 323 |
|
|
2013
Q3 | – | Sell |
-2,940
| Closed | -$115K | – | 1320 |
|
|
2013
Q2 | $115K | Buy |
+2,940
| New | +$115K | ﹤0.01% | 1145 |
|